Skip to content
OpenCapital
Get started

Mid Penn Bancorp MPB Loans collectively evaluated for impairment - associated allowance

Loans collectively evaluated for impairment - associated allowance at other companies

Center Bancorp logo
Center BancorpCNOB
——

Other financials

Income statement

See full
Revenue$64.9M+35.8%
Net income$8.7M-36.6%
EPS (diluted)$0.36-49.3%

Balance sheet

See full
Cash & equivalents$141.2M+31.6%
Total debt$48.7M+40.0%
Total equity$887.4M+32.9%
Total assets$7.0B+25.6%

Cash flow

See full
Operating cash flow$14.5M+15.5%
CapEx$1.4M-47.6%
Free cash flow$13.0M+33.0%

Valuation

See full
Market cap$869.08M+39.6%
Enterprise value$776.57M+41.2%
P/E17×+4.8×
P/S3.6×+0.2×

Profitability

See full
Net margin21.1%-6.6pp
FCF margin30.9%+6.8pp

Returns & leverage

See full
Return on equity6.6%-1.8pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Mid Penn Bancorp in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment.

The official record: Mid Penn Bancorp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance?
Mid Penn Bancorp (MPB) reported loans collectively evaluated for impairment - associated allowance of $38.31M in Q1 2026.
How has Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance changed year-over-year?
Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance increased by 14.5% year-over-year, from $33.46M to $38.31M.
What is the long-term trend for Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance?
Over 3 years (2021 to 2025), Mid Penn Bancorp's loans collectively evaluated for impairment - associated allowance has grown at a 33.2% compound annual growth rate (CAGR), from $14.41M to $34.04M.